Our results suggest that insulin resistance may be the underlying cause of asthma aggravation in obesity-associated asthma and support strategies targeting insulin resistance, weight reduction, or anti-TGF-β1 management to treat uncontrolled asthma in obese patients. This evidence concerns the gene TGFB1 and obesity due to melanocortin 4 receptor deficiency.